A detailed history of Geneos Wealth Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 12,518 shares of ABT stock, worth $1.41 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,518
Previous 10,124 23.65%
Holding current value
$1.41 Million
Previous $1.05 Million 35.78%
% of portfolio
0.05%
Previous 0.05%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $239,567 - $282,803
2,394 Added 23.65%
12,518 $1.43 Million
Q2 2024

Jul 23, 2024

BUY
$100.73 - $112.44 $24,880 - $27,772
247 Added 2.5%
10,124 $1.05 Million
Q1 2024

May 03, 2024

BUY
$109.52 - $120.96 $17,413 - $19,232
159 Added 1.64%
9,877 $1.12 Million
Q4 2023

Jan 26, 2024

SELL
$90.19 - $110.4 $77,833 - $95,275
-863 Reduced 8.16%
9,718 $1.07 Million
Q3 2023

Oct 11, 2023

BUY
$95.53 - $114.62 $21,112 - $25,331
221 Added 2.13%
10,581 $1.02 Million
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $56,134 - $62,545
557 Added 5.68%
10,360 $1.13 Million
Q1 2023

Apr 25, 2023

SELL
$96.86 - $114.01 $58,794 - $69,204
-607 Reduced 5.83%
9,803 $992,000
Q4 2022

Jan 30, 2023

BUY
$95.06 - $111.52 $64,545 - $75,722
679 Added 6.98%
10,410 $1.14 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $1.44 Million - $1.67 Million
-14,905 Reduced 60.5%
9,731 $941,000
Q2 2022

Jul 22, 2022

SELL
$102.07 - $123.37 $182,807 - $220,955
-1,791 Reduced 6.78%
24,636 $2.68 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $219,374 - $267,512
-1,924 Reduced 6.79%
26,427 $3.13 Million
Q4 2021

Feb 09, 2022

SELL
$115.53 - $141.46 $1.32 Million - $1.62 Million
-11,420 Reduced 28.71%
28,351 $3.99 Million
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $16,332 - $18,068
140 Added 0.35%
39,771 $4.66 Million
Q2 2021

Jul 08, 2021

SELL
$105.79 - $124.53 $833,519 - $981,171
-7,879 Reduced 16.58%
39,631 $4.68 Million
Q1 2021

Jun 17, 2021

BUY
$108.84 - $128.23 $206,251 - $242,995
1,895 Added 4.15%
47,510 $5.71 Million
Q4 2020

May 19, 2021

BUY
$105.0 - $114.42 $182,490 - $198,861
1,738 Added 3.96%
45,615 $4.94 Million
Q3 2020

Sep 07, 2021

SELL
$91.64 - $111.29 $297,555 - $361,358
-3,247 Reduced 6.89%
43,877 $4.54 Million
Q2 2020

Sep 07, 2021

BUY
$76.57 - $98.0 $56,968 - $72,912
744 Added 1.6%
47,124 $4.18 Million
Q1 2020

Sep 07, 2021

SELL
$62.82 - $91.86 $98,941 - $144,679
-1,575 Reduced 3.28%
46,380 $3.46 Million
Q4 2019

Sep 07, 2021

BUY
$78.51 - $87.4 $392 - $437
5 Added 0.01%
47,955 $4.19 Million
Q3 2019

Sep 07, 2021

SELL
$81.84 - $88.74 $57,206 - $62,029
-699 Reduced 1.44%
47,950 $3.92 Million
Q2 2019

Sep 07, 2021

SELL
$72.88 - $85.0 $118,211 - $137,870
-1,622 Reduced 3.23%
48,649 $4.09 Million
Q1 2019

Sep 07, 2021

SELL
$66.22 - $80.06 $198,924 - $240,500
-3,004 Reduced 5.64%
50,271 $4.02 Million
Q4 2018

Sep 07, 2021

SELL
$65.56 - $74.27 $168,489 - $190,873
-2,570 Reduced 4.6%
53,275 $3.79 Million
Q3 2018

Sep 07, 2021

BUY
$60.81 - $73.36 $843,617 - $1.02 Million
13,873 Added 33.05%
55,845 $4.1 Million
Q2 2018

Sep 07, 2021

SELL
$57.57 - $63.54 $246,917 - $272,523
-4,289 Reduced 9.27%
41,972 $2.56 Million
Q1 2018

Sep 07, 2021

SELL
$56.27 - $63.62 $71,687 - $81,051
-1,274 Reduced 2.68%
46,261 $2.77 Million
Q4 2017

Sep 07, 2021

SELL
$53.68 - $57.47 $96,624 - $103,446
-1,800 Reduced 3.65%
47,535 $2.71 Million
Q3 2017

Sep 07, 2021

SELL
$48.06 - $53.64 $151,052 - $168,590
-3,143 Reduced 5.99%
49,335 $2.63 Million
Q2 2017

Sep 07, 2021

SELL
N/A
-560 Reduced 1.06%
52,478 $2.55 Million
Q1 2017

Sep 07, 2021

BUY
N/A
3,945 Added 8.04%
53,038 $2.36 Million
Q4 2016

Sep 07, 2021

SELL
N/A
-6,693 Reduced 12.0%
49,093 $1.89 Million
Q3 2016

Sep 07, 2021

SELL
N/A
-2,691 Reduced 4.6%
55,786 $2.36 Million
Q2 2016

Sep 07, 2021

BUY
N/A
9,420 Added 19.2%
58,477 $2.31 Million
Q1 2016

Sep 07, 2021

BUY
N/A
49,057
49,057 $2.07 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.